Clopidogrel Bisulfate
Product Images NDC 54868-6336

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Clopidogrel Bisulfate (NDC 54868-6336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (6336)

Container (6336)
This is a medication labeled as "Plavix" (Clopidogrel bisulfate 75mg) manufactured by Physicians Total Care. The medication comes in a bottle containing 30 tablets. Unfortunately, there is no information available on the intended use or further instructions.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This is a table showing the effect of co-administered PPI on the active metabolite AUC (area under the curve) of different drugs, including Dexlansoprazole, Lansoprazole, Pantoprazole, and Omeprazole. The values in the table represent the mean and 90% confidence interval. However, there is no clear interpretation or context for these numbers, so their significance is unclear.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
The text provides a comparison of the efficacy of two pharmaceutical drugs, Placebo (+ aspirin)® and Clopidogrel + aspirin, on some measurable outcome, probably related to cardiovascular health, over a period of seven months. The text mentions "cumulative event rate" as the outcome but does not specify what it means. Other standard therapies were used in conjunction with these drugs.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
The text appears to be a table showing the percentage of events under different categories and treatments. The categories include age ranges, race, and different treatments such as Beta-Blockers and ACEL. The total number of events and percentages are given for each category. There is not much context to indicate what the events may refer to, but it appears to be part of a medical or research document.*
FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Figure8 (Figure8)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.